Can cord blood Tregs suppress autoimmunity?
Utilizing a patient’s own immune system to treat autoimmunity in type 1 diabetes – the Brusko Lab publishes novel methods to grow regulatory T cells from cryopreserved umbilical cord blood.
Utilizing a patient’s own immune system to treat autoimmunity in type 1 diabetes – the Brusko Lab publishes novel methods to grow regulatory T cells from cryopreserved umbilical cord blood.
Using rare human samples made available through the nPOD program (JDRFnPOD.org), the Brusko Laboratory has new findings to report on the diversity and frequency of autoreactive lymphocytes in T1D.
Tomorrow’s doctors and scientists will be heading home after completing the Student Science Training Program at UF this summer. Come back to visit us often, Keshav.
On July 14, Dr. Wen-I Yeh, her husband, Chun-Wei, and daughter, Zoe, welcomed in their newest family member, Charlotte, into the outside world! …
Ashley Bushdorf and Roshini Pudhucode were recently given the Presidential Service Award for their work as UF Health volunteers.
Dr. Daniel Perry has been notified by the JDRF that his Postdoctoral Fellowship proposal entitled “Altered Immunometabolic Associations With Type 1 Diabetes Clinical Status and Genetic Risk” has been funded!…
The Brusko Lab received a 5-yr, $1,250,000 NIH (R01) grant from the National Diabetes and Digestive and Kidney Diseases (NIDDK) entitled “The CD226 and TIGIT co-stimulatory axis in type 1 diabetes”.
TIGIT and CD226 provide important phenotypic markers for assessing the role of Tregs in health and disease…
Immune therapy for treating type 1 diabetes challenges existing paradigms…
During a live webinar, physicians and medical researchers from around the globe learned that a $3.3M grant has been awarded to nPOD collaborators at UM and UF.